imipramine has been researched along with ketanserin in 48 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (22.92) | 18.7374 |
| 1990's | 12 (25.00) | 18.2507 |
| 2000's | 7 (14.58) | 29.6817 |
| 2010's | 18 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, C; Caldwell, L; Kinnier, WJ; Lancaster, J; McMillan, B; Price, CH; Sweetnam, PM | 1 |
| Bartoccini, F; Carminati, P; Castorina, M; Di Cesare, MA; Di Serio, S; Gallo, G; Ghirardi, O; Giorgi, F; Giorgi, L; Minetti, P; Piersanti, G; Tarzia, G; Tinti, MO | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Altenbach, RJ; Brioni, JD; Carr, TL; Chandran, P; Cowart, MD; Esbenshade, TA; Honore, P; Hsieh, GC; Lewis, LG; Liu, H; Manelli, AM; Marsh, KC; Milicic, I; Miller, TR; Strakhova, MI; Vortherms, TA; Wakefield, BD; Wetter, JM; Witte, DG | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Hayashi, S; Kato, A; Mizuno, K; Morita, A; Nakata, E; Ohashi, K; Yamamura, K | 1 |
| Colau, D; Dolusić, E; Frédérick, R; Larrieu, P; Masereel, B; Moineaux, L; Pilotte, L; Pochet, L; Stroobant, V; Van den Eynde, B; Wouters, J | 1 |
| Dalvie, D; Loi, CM; Smith, DA | 1 |
| Anzini, M; Brogi, S; Butini, S; Campiani, G; Cappelli, A; Caselli, G; Castriconi, F; Gemma, S; Giordani, A; Giorgi, G; Giuliani, G; Lanza, M; Letari, O; Makovec, F; Manini, M; Mennuni, L; Valenti, S | 1 |
| Belyakov, S; Dambrova, M; Kazoka, H; Kuznecovs, J; Lebedev, A; Liepinsh, E; Mishnev, A; Orlova, N; Ponomaryov, Y; Vavers, E; Veinberg, G; Vikainis, S; Vilskersts, R; Vorona, M; Zvejniece, L | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bienkowski, P; Bucki, A; Jaśkowska, J; Kazek, G; Kowalski, P; Kołaczkowski, M; Marcinkowska, M; Mierzejewski, P; Mitka, K; Pawłowski, M; Siwek, A; Wasik, A; Wesołowska, A | 1 |
| Bienkowski, P; Bucki, A; Jastrzębska-Więsek, M; Kazek, G; Kołaczkowski, M; Marcinkowska, M; Mierzejewski, P; Partyka, A; Pawłowski, M; Siwek, A; Śniecikowska, J; Wasik, A; Wesołowska, A | 1 |
| Bednarski, M; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pękala, E; Powroźnik, B; Słoczyńska, K; Walczak, M; Waszkielewicz, AM; Żesławska, E | 1 |
| Filipek, B; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pańczyk, K; Pękala, E; Rapacz, A; Słoczyńska, K; Waszkielewicz, AM; Żelaszczyk, D; Żesławska, E | 1 |
| Karnovsky, ML; Polanski, M | 1 |
| Alhaider, AA; Mustafa, AA | 1 |
| Mustafa, AA | 1 |
| Breese, GR; Duncan, GE; Hong, JS; Mueller, RA; Paul, IA | 1 |
| Barden, N; Peiffer, A; Veilleux, S | 1 |
| Breese, GR; Duncan, GE; Hong, JS; Kuhn, C; Mueller, RA; Paul, IA | 1 |
| Beni, M; Carla, V; Consolazione, A; Dall'Olio, R; Gandolfi, O; Lombardi, G; Moroni, F; Pellegrini-Giampietro, DE | 1 |
| Brunello, N; Galimberti, R; Racagni, G; Riva, M; Rovescalli, AC | 1 |
| Barkai, AI; Butler, PD; Edwards, E | 1 |
| Mizuta, T; Segawa, T | 1 |
| Eison, AS; Eison, MS; Gianutsos, G; Yocca, FD | 1 |
| Andree, TH; Koenig, JI; Meltzer, HY; Mikuni, M; Tong, CY | 1 |
| Kendall, DA; Nahorski, SR | 1 |
| Anwyl, R; Rowan, MJ | 1 |
| Böhm, W; Bönisch, H; Graefe, KH; Halbrügge, T; Wölfel, R | 1 |
| Barbaccia, ML; Costa, E; Gandolfi, O | 1 |
| Barbaccia, ML; Chuang, DM; Costa, E; Gandolfi, O | 1 |
| Parker, D | 1 |
| Klimek, V; Papp, M; Willner, P | 1 |
| Endoh, M; Morinobu, S; Okuyama, N; Totsuka, S | 1 |
| Duman, RS; Morinobu, S; Strausbaugh, H; Terwilliger, R | 1 |
| Bourin, M; Redrobe, JP | 1 |
| Jeanningros, R; Mazzola-Pomietto, P; Moreau, X | 1 |
| Sugimoto, Y; Yamada, J | 1 |
| Akiyama, K; Fujitani, Y; Gomita, Y; Kanzaki, H; Kawasaki, H; Kimoto, S; Kitagawa, K; Kitamura, Y; Ouchida, M; Sendo, T; Shibata, K; Shimizu, K | 1 |
| Arango, V; Bakalian, MJ; Galfalvy, H; Kassir, SA; Mann, JJ; Underwood, MD | 1 |
| Lee, MJ; Wei, JW | 1 |
| Matsumoto, K; Oka, JI; Sasaki-Hamada, S; Suzuki, A; Ueda, Y | 1 |
| Fiorino, F; Kędzierska, E; Knap, B; Kotlińska, JH; Magli, E; Orzelska-Górka, J; Poleszak, E; Wlaź, P | 1 |
| Faron-Górecka, A; Filip, M; Gawlińska, K; Gawliński, D; Smaga, I; Zaniewska, M | 1 |
1 review(s) available for imipramine and ketanserin
| Article | Year |
|---|---|
The role of receptor binding in drug discovery.
Topics: Animals; Drug Design; Humans; Receptors, Drug | 1993 |
47 other study(ies) available for imipramine and ketanserin
| Article | Year |
|---|---|
2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization.
Topics: Adenine; Adenosine A2 Receptor Antagonists; Animals; Cell Line; Cricetinae; Cricetulus; Drug Design; Humans; Imidazoles; Male; Models, Molecular; Motor Activity; Purines; Radioligand Assay; Rats; Rats, Inbred F344; Structure-Activity Relationship; Triazoles | 2005 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzofurans; Carrageenan; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Humans; Hyperalgesia; Ligands; Mice; Molecular Structure; Pain; Peritonitis; Quinazolines; Rats; Receptors, G-Protein-Coupled; Receptors, Histamine; Receptors, Histamine H4; Stereoisomerism; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: de
Topics: Analgesics; Animals; Benzimidazoles; Drug Design; Drug Evaluation, Preclinical; Humans; Microsomes, Liver; Neuralgia; Nociceptin Receptor; Pyrroles; Rats; Receptors, Opioid; Structure-Activity Relationship | 2010 |
Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators.
Topics: Animals; Antineoplastic Agents; Biological Availability; Cell Line; Drug Design; Enzyme Inhibitors; Humans; Immunologic Factors; Indoles; Kinetics; Mice; Neoplasms; Structure-Activity Relationship; Tryptophan Oxygenase | 2011 |
Which metabolites circulate?
Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations | 2013 |
Synthesis and structure-activity relationship studies in serotonin 5-HT(1A) receptor agonists based on fused pyrrolidone scaffolds.
Topics: Animals; Area Under Curve; Humans; Intestinal Absorption; Ligands; Male; Metabolic Clearance Rate; Models, Chemical; Models, Molecular; Molecular Structure; Protein Binding; Protein Structure, Tertiary; Pyrrolidinones; Radioligand Assay; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin, 5-HT3; Serotonin 5-HT1 Receptor Agonists; Structure-Activity Relationship | 2013 |
Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor.
Topics: Acetamides; Allosteric Regulation; Animals; Rats; Rats, Wistar; Receptors, sigma; Sigma-1 Receptor; Stereoisomerism; Structure-Activity Relationship | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Novel arylsulfonamide derivatives with 5-HT₆/5-HT₇ receptor antagonism targeting behavioral and psychological symptoms of dementia.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Avoidance Learning; Benzoxazoles; Catalepsy; CHO Cells; Cricetulus; Dementia; Dopamine D2 Receptor Antagonists; HEK293 Cells; Humans; Male; Models, Molecular; Motor Activity; Radioligand Assay; Rats, Wistar; Receptors, Serotonin; Serotonin Antagonists; Structure-Activity Relationship; Sulfonamides | 2014 |
Novel 5-HT6 receptor antagonists/D2 receptor partial agonists targeting behavioral and psychological symptoms of dementia.
Topics: Animals; Benzamides; Dementia; Dose-Response Relationship, Drug; Drug Partial Agonism; Humans; Indoles; Ligands; Male; Models, Molecular; Molecular Structure; Piperazines; Quinolones; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Serotonin; Structure-Activity Relationship; Swimming | 2015 |
Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.
Topics: Amino Alcohols; Animals; Anticonvulsants; Chemistry, Physical; Dose-Response Relationship, Drug; Drug Design; Epilepsy; Male; Mice; Microsomes, Liver; Molecular Structure; Pilocarpine | 2016 |
Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH
Topics: Amino Alcohols; Animals; Anticonvulsants; Crystallography, X-Ray; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Mice; Models, Molecular; Molecular Structure; Rats; Seizures; Structure-Activity Relationship | 2017 |
Serotonergic aspects of the response of human platelets to immune-adjuvant muramyl dipeptide.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adenosine Diphosphate; Adjuvants, Immunologic; Blood Platelets; Carrier Proteins; Humans; Imipramine; Ketanserin; Lysergic Acid Diethylamide; Paroxetine; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Serotonin; Serotonin; Serotonin Antagonists | 1992 |
Enhancement of imipramine-induced rat brain beta-adrenoreceptor desensitization by subacute co-administration of trazodone, zimelidine, quipazine or 5-hydroxytryptophan.
Topics: 5-Hydroxytryptophan; Animals; Brain Chemistry; Drinking Behavior; Female; Fenclonine; Imipramine; Isoproterenol; Ketanserin; Methysergide; Propranolol; Quipazine; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Serotonin Antagonists; Trazodone; Zimeldine | 1991 |
Rapid desensitization of central beta-adrenoceptors in rat after subacute treatment with imipramine and calcium entry blockers.
Topics: 1-Propanol; Animals; Calcium Channel Blockers; Clonidine; Diltiazem; DOM 2,5-Dimethoxy-4-Methylamphetamine; Drinking Behavior; Fenclonine; Imipramine; Isoproterenol; Ketanserin; Nicardipine; Nifedipine; Oxidopamine; Rats; Receptors, Adrenergic, beta; Verapamil | 1991 |
Neural adaptation in response to chronic imipramine and electroconvulsive shock: evidence for separate mechanisms.
Topics: Animals; Brain; Dynorphins; Electroshock; Imipramine; Ketanserin; Male; Radioimmunoassay; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Receptors, Serotonin; Thyrotropin-Releasing Hormone | 1991 |
Antidepressant and other centrally acting drugs regulate glucocorticoid receptor messenger RNA levels in rat brain.
Topics: Amygdala; Animals; Antidepressive Agents; Blotting, Northern; Brain; Brain Chemistry; Desipramine; Female; Hippocampus; Hypothalamo-Hypophyseal System; Hypothalamus; Imipramine; Ketanserin; Lithium; Male; Pituitary-Adrenal System; Rats; Rats, Inbred Strains; Receptors, Glucocorticoid; RNA, Messenger; Sex Characteristics; Up-Regulation | 1991 |
Neural adaptation in imipramine-treated rats processed in forced swim test: assessment of time course, handling, rat strain and amine uptake.
Topics: Adaptation, Physiological; Animals; Behavior, Animal; Cerebral Cortex; Corticosterone; Dihydroalprenolol; Fluoxetine; Hippocampus; Imipramine; Ketanserin; Male; Physical Exertion; Rats; Rats, Inbred F344; Rats, Inbred Strains; Receptors, Adrenergic, beta; Receptors, GABA-A; Species Specificity; Swimming | 1990 |
Lesioning and recovery of the serotoninergic projections to the hippocampus.
Topics: Animals; Behavior, Animal; Brain; Hippocampus; Hydroxyindoleacetic Acid; Imipramine; Ketanserin; Kinetics; Mianserin; Nerve Regeneration; Neural Pathways; Rats; Receptors, Serotonin; Serotonin; Synaptosomes | 1987 |
Age-related changes in rat serotonergic and adrenergic systems and in receptor responsiveness to subchronic desipramine treatment.
Topics: Aging; Animals; Brain; Clonidine; Desipramine; Dihydroalprenolol; Hydroxyindoleacetic Acid; Imipramine; Ketanserin; Kinetics; Male; Paroxetine; Piperidines; Prazosin; Proteins; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Receptors, Serotonin; Serotonin; Time Factors | 1988 |
Imipramine and tetrabenazine: effects on monoamine receptor binding sites and phosphoinositide hydrolysis.
Topics: Animals; Dihydroalprenolol; Hydrolysis; Imipramine; Inositol Phosphates; Ketanserin; Kinetics; Male; Phosphatidylinositols; Prazosin; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Receptors, Serotonin; Tetrabenazine | 1989 |
Chronic effects of imipramine and lithium on 5-HT receptor subtypes in rat frontal cortex, hippocampus and choroid plexus: quantitative receptor autoradiographic analysis.
Topics: Animals; Autoradiography; Brain Chemistry; Cerebral Cortex; Choroid Plexus; Hippocampus; Imipramine; Iodine Radioisotopes; Ketanserin; Lithium; Male; Rats; Rats, Inbred Strains; Receptors, Serotonin; Spiperone | 1989 |
Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation.
Topics: 5,7-Dihydroxytryptamine; Animals; Cerebral Cortex; Cerebral Ventricles; Fluoxetine; Imipramine; Ketanserin; Kinetics; Male; Neurons; Quinolines; Quipazine; Rats; Rats, Inbred Strains; Receptors, Serotonin; Reference Values; Serotonin; Stereotyped Behavior | 1989 |
Differential effect of subchronic treatment with various neuroleptic agents on serotonin2 receptors in rat cerebral cortex.
Topics: 5,7-Dihydroxytryptamine; Animals; Antipsychotic Agents; Cerebral Cortex; Chlorpromazine; Clozapine; Female; Haloperidol; Imipramine; Ketanserin; Loxapine; Male; Piperidines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Spiperone; Sulpiride | 1986 |
5-Hydroxytryptamine-stimulated inositol phospholipid hydrolysis in rat cerebral cortex slices: pharmacological characterization and effects of antidepressants.
Topics: Affinity Labels; Animals; Antidepressive Agents; Cerebral Cortex; Hydrolysis; Imipramine; Iprindole; Ketanserin; Male; Phenoxybenzamine; Phosphatidylinositols; Piperidines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin | 1985 |
The effect of prolonged treatment with tricyclic antidepressants on the actions of 5-hydroxytryptamine in the hippocampal slice of the rat.
Topics: Animals; Cyproheptadine; Desipramine; Evoked Potentials; Hippocampus; Imipramine; In Vitro Techniques; Ketanserin; Male; Piperidines; Rats; Rats, Inbred Strains; Serotonin | 1985 |
On the 5-hydroxytryptamine transport across the plasma membrane of rabbit platelets and its inhibition by imipramine.
Topics: Animals; Biological Transport, Active; Blood Platelets; Blood Proteins; Cell Membrane; Female; Imipramine; In Vitro Techniques; Ketanserin; Male; Rabbits; Serotonin; Time Factors | 1988 |
Comparison of iprindole, imipramine and mianserin action on brain serotonergic and beta adrenergic receptors.
Topics: Animals; Axons; Brain; Cyclic AMP; Dibenzazepines; Imipramine; Indoles; Iprindole; Ketanserin; Male; Mianserin; Norepinephrine; Piperidines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Receptors, Serotonin | 1984 |
Differences in the regulatory adaptation of the 5HT recognition sites labelled by 3H-mianserin or 3H-ketanserin.
Topics: Animals; Axons; Dibenzazepines; Hippocampus; Imipramine; Ketanserin; Male; Mianserin; Piperidines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin Antagonists; Synapses; Tritium | 1983 |
Serotonergic modulation of locust motor neurons.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Cyclic AMP; Dose-Response Relationship, Drug; Female; Grasshoppers; Imipramine; Ketanserin; Male; Motor Neurons; Serotonin; Tibia; Time Factors | 1995 |
Effects of imipramine on serotonergic and beta-adrenergic receptor binding in a realistic animal model of depression.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Behavior, Animal; Depression; Dihydroalprenolol; Imipramine; Ketanserin; Kinetics; Male; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Receptors, Serotonin; Stress, Psychological | 1994 |
Enhancement of 5-hydroxytryptamine-stimulated phosphoinositide hydrolysis in the rat cerebral cortex by repeated immobilization stress.
Topics: Animals; Body Weight; Cerebral Cortex; Hydrolysis; Imipramine; Immobilization; Ketanserin; Male; Phosphatidylinositols; Prazosin; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin; Stress, Physiological | 1995 |
Regulation of c-Fos and NGF1-A by antidepressant treatments.
Topics: Adrenergic Antagonists; Animals; Antidepressive Agents; Benzazepines; Blotting, Western; Dizocilpine Maleate; DNA-Binding Proteins; Dopamine Antagonists; Early Growth Response Protein 1; Electroshock; Excitatory Amino Acid Antagonists; Frontal Lobe; Genes, fos; Genes, Immediate-Early; Haloperidol; Imipramine; Immediate-Early Proteins; Ketanserin; Male; Prazosin; Propranolol; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Transcription Factors; Transcription, Genetic; Tranylcypromine | 1997 |
Partial role of 5-HT2 and 5-HT3 receptors in the activity of antidepressants in the mouse forced swimming test.
Topics: Amphetamines; Animals; Antidepressive Agents; Behavior, Animal; Citalopram; Desipramine; Drug Interactions; Fluoxetine; Fluvoxamine; Imipramine; Ketanserin; Male; Maprotiline; Mice; Ondansetron; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Ritanserin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Swimming | 1997 |
Chronic effects of triiodothyronine in combination with imipramine on 5-HT transporter, 5-HT(1A) and 5-HT(2A) receptors in adult rat brain.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antidepressive Agents, Tricyclic; Body Weight; Brain; Carrier Proteins; Citalopram; Depressive Disorder; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Imipramine; Ketanserin; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neurons; Radioligand Assay; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists; Thyroid Gland; Time Factors; Triiodothyronine | 2001 |
Effects of 5-HT(2) receptor antagonists on the anti-immobility effects of imipramine in the forced swimming test with mice.
Topics: Animals; Antidepressive Agents, Tricyclic; Dose-Response Relationship, Drug; Ergolines; Imipramine; Indoles; Ketanserin; Male; Mice; Motor Activity; Pyridines; Receptors, Serotonin; Serotonin Antagonists; Swimming | 2001 |
Increased DOI-induced wet-dog shakes in adrenocorticotropic hormone-treated rats are not affected by chronic imipramine treatment: possible involvement of enhanced 5-HT(2A)-receptor expression in the frontal cortex.
Topics: Adrenocorticotropic Hormone; Amphetamines; Animals; Antidepressive Agents, Tricyclic; Binding Sites; Cerebral Cortex; Disease Models, Animal; Hydroxyindoleacetic Acid; Imipramine; Ketanserin; Male; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; RNA, Messenger; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Time Factors; Tremor; Up-Regulation | 2008 |
Neuron density and serotonin receptor binding in prefrontal cortex in suicide.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adolescent; Adult; Aged; Autoradiography; Case-Control Studies; Depressive Disorder, Major; Female; Humans; Imipramine; Ketanserin; Male; Middle Aged; Neurons; Postmortem Changes; Prefrontal Cortex; Protein Binding; Receptors, Serotonin; Serotonin Agents; Suicide; Tritium; Up-Regulation; Young Adult | 2012 |
The influences of reserpine and imipramine on the 5-HT2 receptor binding site and its coupled second messenger in rat cerebral cortex.
Topics: Animals; Antidepressive Agents; Binding Sites; Cerebral Cortex; Imipramine; Inositol Phosphates; Ketanserin; Male; Rats; Rats, Sprague-Dawley; Receptors, Serotonin, 5-HT2; Reserpine; Serotonin; Synaptic Membranes | 2013 |
Serotonergic and dopaminergic systems are implicated in antidepressant-like effects of chotosan, a Kampo formula, in mice.
Topics: Animals; Antidepressive Agents; Disease Models, Animal; Dopamine Agents; Drugs, Chinese Herbal; Fenclonine; Imipramine; Ketanserin; Locomotion; Male; Medicine, Kampo; Metergoline; Mice; Piperazines; Pyridines; Serotonin Agents; Sulpiride; Swimming; Yohimbine | 2017 |
New arylpiperazine derivatives with antidepressant-like activity containing isonicotinic and picolinic nuclei: evidence for serotonergic system involvement.
Topics: Animals; Antidepressive Agents; Hindlimb Suspension; Imipramine; Ketanserin; Male; Mice; Motor Activity; Picolines; Piperazines; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin | 2019 |
Adaptive mechanisms following antidepressant drugs: Focus on serotonin 5-HT
Topics: Acetylcysteine; Animals; Antidepressive Agents; Autoradiography; Benzamides; Brain; Carbamates; Citalopram; Imipramine; Ketanserin; Male; Nucleus Accumbens; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Thiazepines | 2019 |